News Conference News ACC 2026 Clinician EHR Alerts Lead to Speedier Evaluation, Treatment of Valve Disease Todd Neale April 01, 2026
News Conference News ACC 2026 Transcatheter ViV a Solid Option for Failed Mitral Bioprostheses: SURViV Caitlin E. Cox March 30, 2026
News Conference News ACC 2026 Impella Support in High-Risk PCI Doesn’t Help, Might Harm: CHIP-BCIS3 Yael L. Maxwell March 29, 2026
Presentation ACC 2026 Redo-SURgery vs Transcatheter Valve-In-Valve for Mitral Bioprosthetic Dysfunction: The SURVIV Trial Presenter: Dimytri Siqueira March 29, 2026
News Daily News Suspended Lead Suit Brings Radiation Exposure Down to Zero for Many Structural Imagers Yael L. Maxwell March 13, 2026
News Conference News THT 2026 Should Moderate FMR Be Treated With M-TEER? Experts Duke It Out Todd Neale March 06, 2026
News Daily News Experience Matters as Ross Procedure Gains Popularity in North America Michael O'Riordan March 06, 2026
News Conference News THT 2026 NT-proBNP Provides Info on Who Will Fare Well After Tricuspid TEER Todd Neale March 04, 2026
Presentation THT 2026 LAVA ECMO Support in Severe Mitral Regurgitation as a Bridge to Mitral Valve Repair Presenter: Som Singh March 04, 2026
Presentation THT 2026 Echocardiographic Assessment of Pulmonary Vascular Resistance Changes and Clinical Outcomes Following Transcatheter Mitral Valve Edge-to-Edge Repair Presenter: Frailyn J. Nunez March 03, 2026
Presentation THT 2026 Early Human Feasibility Experience with a Novel Transcatheter Cardiac Leaflet Enhancer (CARLEN) to Treat Functional Mitral Regurgitation in Heart Failure reduced Ejection Fraction Presenter: Edwin Ho March 03, 2026
Presentation THT 2026 Impact of Baseline Tricuspid Regurgitation on Outcomes in Heart Failure Patients Undergoing Mitral TEER Presenter: Thitiphan Srikulmontri March 03, 2026
Presentation THT Abstracts 2026 Intranasal Bumetanide as an Effective Non-Oral Diuretic Strategy in a Patient With Diuretic-Resistant Heart Failure Awaiting Transcatheter Mitral Valve Replacement Presenter: Joshua Rushakoff March 02, 2026
Presentation THT Abstracts 2026 Echocardiographic Assessment of Pulmonary Vascular Resistance Changes and Clinical Outcomes Following Mitral Valve Edge-to-Edge Repair Presenter: Frailyn Nunez March 02, 2026
Presentation THT Abstracts 2026 A Retrospective Analysis of Heart Failure Hospitalization Trends in Patients with Functional Mitral Regurgitation in a Real-world Clinical Setting Presenter: Colin Barker March 02, 2026
Presentation THT Abstracts 2026 Baseline NT-proBNP Predicts Outcomes After Transcatheter Edge-to-Edge Repair for Secondary Mitral Regurgitation with Preserved Ejection Fraction: The REPAIR Study Presenter: Philipp von Stein March 02, 2026
Presentation THT Abstracts 2026 Rethinking Rheumatic Mitral Stenosis: Repeat Percutaneous Mitral Valve Repair as a Viable Option Presenter: Ezra Schneier March 02, 2026
News Daily News Surgical Mitral Valve Repair Outcomes ‘Excellent’ at 2 Years: CTSN Yael L. Maxwell February 26, 2026